Document Detail


Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line.
MedLine Citation:
PMID:  18599154     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Epithelial to mesenchymal transition (EMT) has been reported to be related with reduced sensitivity to EGFR tyrosine kinase (EGFR-TK) inhibitors. We performed this study to investigate whether this phenomenon would play a role in acquired resistance to gefitinib. In this study, we established a gefitinib-resistant subline (A549/GR), which was derived from the parental A549 cell line by chronic, repeated exposure to gefitinib. Compared with the A549 cells, the A549/GR cells were approximately 7.7-fold more resistant to gefitinib and they showed the cross-resistance against other EGFR-TK inhibitors, including CL-387,758, erlotinib and ZD6478. Phenotypic changes such as a spindle-cell shape and increased pseudopodia formation suggesting EMT was present in the A549/GR cells. These changes were accompanied by a decrease of E-cadherin and an increase of vimentin, which is a mesenchymal marker. In addition, the ability of invasion and migration was increased in the A549/GR cells. TGF-beta1 treatment for 72 h also induced EMT in the A549 cells and this transition led to resistance to gefitinib. Conversely, this was reversed through the removal of TGF-beta1. In conclusion, induction of EMT may contribute to the decreased efficacy of therapy in primary and acquired resistance to gefitinib.
Authors:
Jin Kyung Rho; Yun Jung Choi; Jin Kyung Lee; Baek-Yeol Ryoo; Im Il Na; Sung Hyun Yang; Cheol Hyeon Kim; Jae Cheol Lee
Related Documents :
19525224 - 14-3-3zeta mediates resistance of diffuse large b cell lymphoma to an anthracycline-bas...
8274294 - Selection and characterization of a variant of human melanoma cell line, a375 resistant...
20164584 - Presenilin-1 holoprotein is an interacting partner of sarco endoplasmic reticulum calci...
8384234 - Antiproliferative effects of interferons -alpha and -beta in combination with 5-fluorou...
11579084 - A protective role for kidney apolipoprotein e. regulation of mesangial cell proliferati...
14637384 - Resiniferatoxin-induced loss of plasma membrane in vanilloid receptor expressing cells.
Publication Detail:
Type:  Journal Article     Date:  2008-07-02
Journal Detail:
Title:  Lung cancer (Amsterdam, Netherlands)     Volume:  63     ISSN:  0169-5002     ISO Abbreviation:  Lung Cancer     Publication Date:  2009 Feb 
Date Detail:
Created Date:  2009-01-06     Completed Date:  2009-03-10     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  8800805     Medline TA:  Lung Cancer     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  219-26     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological & Medical Science, Seoul 139-706, Republic of Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / pharmacology*
Carcinoma, Non-Small-Cell Lung / drug therapy*,  pathology
Cell Line, Tumor
Cell Movement
Drug Resistance, Neoplasm
Epithelium / pathology*
Humans
Lung Neoplasms / drug therapy*,  pathology
Mesoderm / pathology*
Neoplasm Invasiveness
Protein Kinase Inhibitors / pharmacology*
Proto-Oncogene Proteins c-akt / metabolism
Quinazolines / pharmacology*
Receptor, Epidermal Growth Factor / antagonists & inhibitors*
Transforming Growth Factor beta1 / pharmacology
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Protein Kinase Inhibitors; 0/Quinazolines; 0/Transforming Growth Factor beta1; 184475-35-2/gefitinib; EC 2.7.10.1/Receptor, Epidermal Growth Factor; EC 2.7.11.1/Proto-Oncogene Proteins c-akt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: inverse corre...
Next Document:  Nature of the nuclear inclusions formed by PQBP1, a protein linked to neurodegenerative polyglutamin...